Akero Therapeutics Stock Forward View

Akero Therapeutics Additional Predictive Modules

Most predictive techniques to examine Akero price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Akero using various technical indicators. When you analyze Akero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Akero Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Akero Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Akero Therapeutics Naive Prediction Price Forecast For the 3rd of February

Given 90 days horizon, the Naive Prediction forecasted value of Akero Therapeutics on the next trading day is expected to be 54.90 with a mean absolute deviation of 0.84, mean absolute percentage error of 1.83, and the sum of the absolute errors of 50.98.

Akero Therapeutics Stock Forecast Pattern

Backtest Akero Therapeutics

Akero Therapeutics Price Prediction

Research Analysis

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Akero Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Akero Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Akero Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Akero Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Akero Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Akero Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 54.49 54.64 54.79 Details

Intrinsic Valuation Low Real High 43.66 43.81 60.12 Details

Bollinger Band Projection (param) Low Middle High 53.98 54.37 54.76 Details

Akero Therapeutics After-Hype Price Density Analysis

Akero Therapeutics Estimiated After-Hype Price Volatility

Akero Therapeutics Stock Price Outlook Analysis

Notes

Akero Therapeutics Hype Timeline

Akero Therapeutics is presently traded for 54.65. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Akero is projected to decline in value after the next headline, with the price expected to drop to 54.64. The average volatility of media hype impact on the company price is about 60.0%. The price decrease on the next news is expected to be -0.02%, whereas the daily expected return is presently at 0.04%. The volatility of related hype on Akero Therapeutics is about 1000.0%, with the expected price after the next announcement by competition of 54.65. About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Akero Therapeutics was presently reported as 11.95. The company has Price/Earnings To Growth (PEG) ratio of 0.93. Akero Therapeutics recorded a loss per share of 3.75. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 4 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.

Akero Therapeutics Related Hype Analysis

Akero Therapeutics Related Equities

Risk & Return

Correlation

Akero Therapeutics Market Strength Events

Akero Therapeutics Risk Indicators

Story Coverage note for Akero Therapeutics

Akero Therapeutics Short Properties

Other Consideration for investing in Akero Stock